Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 60.85 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 73.27 | Oscillator | Neutral |
| Williams %R (14) | -21.33 | Oscillator | Neutral |
| MACD (12, 26, 9) | 3.06 (Hist 0.58) | Oscillator | Strong Buy |
| Average Directional Index (14) | 18.95 (+DI 24.8 / -DI 15.1) | Trend | Neutral |
Current price $186.89
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| EMA 20 | 181.48 | MA | Buy |
| SMA 20 | 180.05 | MA | Strong Buy |
| EMA 50 | 176.51 | MA | Strong Buy |
| SMA 50 | 176.70 | MA | Strong Buy |
| SMA 200 | 177.67 | MA | Strong Buy |
| Sep 18, 26 |
| Leerink Partners |
| maintain |
| Outperform |
| Outperform |
| Aug 20, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Aug 3, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Jul 30, 26 | Goldman Sachs | maintain | Neutral | Neutral |
| Jul 29, 26 | Cantor Fitzgerald | maintain | Neutral | Neutral |
| Jul 29, 26 | Guggenheim | maintain | Buy | Buy |
| Jul 29, 26 | Baird | maintain | Neutral | Neutral |
| Jul 29, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jul 28, 26 | Cantor Fitzgerald | maintain | Neutral | Neutral |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 14,163 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 14,163 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 14,163 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 9,418 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 50,990 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 9,418 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 13,963 | — |
| May 27, 26 | Miller Alan B | director, 10 percent owner, officer: Executive Chairman | J-Other | 25,495 | — |
FY2025 · 10-K disclosure
FY2023 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | UHS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 7.6x | 12.1x · sector 20.7x | Discount |
| Forward P/E (FY26E) | 8.3x | EPS est. 22.55 | In line |
| Price / Book | 1.5x | 1.8x | Discount |
| Price / Sales | 0.6x | 0.8x | Discount |
| EV / EBITDA | 5.7x | 8.3x | Discount |
| Return on equity | 20.7% | — | Top tier |
| Gross margin | 90.7% | 89.5% | In line |
| Debt / Equity | 0.70 | 0.80 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 3.14 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G | Oct 19, 2026 | 2026-10-19 11:07:00 | View |
| SC 13G | Oct 8, 2026 | 2026-10-08 14:25:42 | View |
| 8-K | Aug 21, 2026 | 2026-08-21 07:58:07 | View |
| S-8 | Aug 18, 2026 | 2026-08-18 08:50:29 | View |
| 8-K | Aug 17, 2026 | 2026-08-17 16:15:14 | View |
| 8-K | Aug 13, 2026 | 2026-08-13 09:23:03 | View |
| 424B5 | Aug 13, 2026 | 2026-08-13 09:21:01 | View |
| FWP | Aug 12, 2026 | 2026-08-11 19:54:09 | View |
| 424B5 | Aug 10, 2026 | 2026-08-10 09:15:29 | View |
| POSASR | Aug 7, 2026 | 2026-08-07 16:27:52 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Universal Health Services' Q3 revenues are expected to rise on higher patient admissions, but surging operating costs and wage pressures could weigh on earnings growth.
Universal Health Services, Inc. is rated Strong Buy due to undervaluation at 8x forward P/E and resilient earnings growth. Recent guidance cuts reflect mostly temporary challenges, with consolidated revenue and EBITDA still growing across both Acute Care and Behavioral Health segments. Medicaid reimbursement cuts are gradual and manageable, with management repositioning toward outpatient behavioral health and private payors.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 27, 2026 | 5.94 | 5.98 | Beat 0.7% | $4.64B |
| Apr 27, 2026 | 5.41 | 5.62 | Beat 3.9% | $4.50B |
| Feb 25, 2026 | 5.92 | 5.88 | Miss -0.7% | $4.49B |
| Oct 27, 2025 | 4.66 | 5.69 | Beat 22.1% | $4.50B |
| Jul 28, 2025 | 4.92 | 5.35 | Beat 8.7% | $4.28B |
| Apr 28, 2025 | 4.35 | 4.84 | Beat 11.3% | $4.10B |